ACI's 3rd Annual Life Sciences AI Summit

The American Conference Institute (ACI) is hosting its 3rd Annual Life Sciences AI Summit on February 24–25, 2026, at the New York City Bar Association in New York, NY. This two-day event focuses on the legal and regulatory aspects of artificial intelligence (AI) in the life sciences sector, providing attendees with practical, case-based guidance from agency leaders, in-house counsel, and top practitioners.

Key topics include adapting risk and compliance frameworks for next-generation AI, navigating data privacy and transparency in drug development and clinical trials, contracting for AI-enabled systems and services, implementing intellectual property strategies to protect innovation in AI-driven life sciences, understanding the impact of the EU AI Act and U.S. state laws, and exploring emerging litigation trends and governance structures shaping the AI landscape.

The summit features pre-conference workshops on mastering the basics of AI, machine learning, and the data lifecycle, as well as building cohesive AI governance for FDA/EU readiness. Notable speakers include Anindita Saha, Acting Director of Data Science and AI Policy at the FDA, and Zheng Yang, Worldwide Head of AI/ML Strategy and Solutions for Healthcare and Life Sciences at Amazon Web Services. The event also offers networking opportunities and an expo hall showcasing the latest AI technologies in life sciences.

This summit is ideal for professionals in the biopharmaceutical and medical device industries, including legal and compliance officers, regulatory affairs specialists, data scientists, and technology leaders. Attendees will gain actionable insights and tools to implement AI responsibly and at scale within their organizations.